You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

UNIPEN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Unipen, and when can generic versions of Unipen launch?

Unipen is a drug marketed by Wyeth Ayerst and is included in five NDAs.

The generic ingredient in UNIPEN is nafcillin sodium. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the nafcillin sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Unipen

A generic version of UNIPEN was approved as nafcillin sodium by ISTITUTO BIO ITA SPA on April 20th, 2011.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for UNIPEN?
  • What are the global sales for UNIPEN?
  • What is Average Wholesale Price for UNIPEN?
Summary for UNIPEN
Drug patent expirations by year for UNIPEN
Recent Clinical Trials for UNIPEN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Cubist Pharmaceuticals LLCPhase 2

See all UNIPEN clinical trials

US Patents and Regulatory Information for UNIPEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst UNIPEN nafcillin sodium CAPSULE;ORAL 050111-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wyeth Ayerst UNIPEN nafcillin sodium INJECTABLE;INJECTION 050320-005 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wyeth Ayerst UNIPEN nafcillin sodium INJECTABLE;INJECTION 062717-004 Dec 16, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wyeth Ayerst UNIPEN IN PLASTIC CONTAINER nafcillin sodium INJECTABLE;INJECTION 050320-002 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.